1. 1258PBaseline predictive factors for efficacy of anti-PD1 used in first line in melanoma patients: An Italian melanoma intergroup study. (23rd October 2018) Authors: Marconcini, R; Tanda, E; Di Guardo, L A; Nigro, O; Fava, P; Todisco, A; Morgese, F; Cortellini, A; Stroppa, E; Gallizzi, G; Festino, L; Grego, E; Quadrini, S; Orlandini, C; Nuzzo, A; Manacorda, S; Bloise, F; Indini, A; Astrua, C; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin. (September 2022) Authors: Roccuzzo, GR; Fava, P; Avallone, G; Aquino, C; Boskovic, S; Macagno, N; Ribero, S; Quaglino, P Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗